Joint (JYNT) Stock Price

Joint Price

NASDAQ·CLOSED
7.20
​
Market closed

Revenue has compounded at 25.8% per year over the past 13 years to 54.90 M USD. Earnings per share have grown at 22.8% per year over the last 12 years. Joint's net margin stands at 5.3%, down from 9.5% several years earlier. Analysts set a median price target of 20.00 USD, implying 177.6% above the current price. Of 10 analysts, 6 rate the stock a buy — an overall Buy consensus.

Joint stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Joint business model & stock analysis

The Joint Corp is an American company specializing in providing medical and wellness services. It was founded in 2010 and is headquartered in Scottsdale, Arizona. The company currently operates over 600 clinics in the United States and is listed on NASDAQ under the ticker symbol JYNT. Its business model focuses on treating patients with joint and muscle pain through a chain of clinics that specialize in chiropractic, physical therapy, and other wellness-based treatments. The company's main strategy for expansion is through franchise systems, providing support to franchisees in areas such as location selection, building lease, and financing. Joint clinics offer a range of products and services, including chiropractic treatments, physical therapy, sports medicine, acupuncture, supplements, and pain medication. The company has recently partnered with a franchise company in Canada to open clinics in multiple Canadian cities and plans to open clinics in other countries in the coming years. While The Joint brand is known for its affordable wellness concept, it has faced mixed reception from the chiropractic industry due to concerns about quality and patient safety. However, the company has taken steps to address these concerns by hiring qualified chiropractors and physicians and implementing strict quality controls. Overall, The Joint Corp is focused on becoming a leading wellness company in the USA and worldwide, aiming to expand and offer innovative ways to improve patient well-being.

Frequently asked questions about Joint

Joint Corp is primarily present in the United States.

The business model of Joint Corp primarily focuses on providing chiropractic care services. Joint Corp operates a network of chiropractic clinics across the United States, offering convenient and affordable access to chiropractic adjustments. Their model involves providing membership plans and walk-in options for individuals seeking chiropractic treatment for common health issues, including neck and back pain. Joint Corp's unique approach aims to offer standardized care through its proprietary software system, ensuring consistent treatment techniques across their clinics. By emphasizing a membership-based model, Joint Corp aims to create long-term relationships with their customers, enhancing accessibility and affordability for chiropractic care services.

Joint Corp is primarily active in the healthcare industry.

The main competitors of Joint Corp in the market include chiropractic clinics and wellness centers that offer similar services and treatments for musculoskeletal conditions. Some notable competitors include AmeriCare Physical Therapy, The Joint Chiropractic, and The Joint.the chiropractic place. These competitors, like Joint Corp, aim to provide quality chiropractic care and wellness solutions to their customers. However, Joint Corp stands out due to its unique business model of providing affordable and convenient chiropractic services through its nationwide network of franchised clinics.

The Joint Corp, founded in 1999, is a leading chiropractic care company based in Scottsdale, Arizona. With a mission to improve the quality of life through chiropractic care, the company operates over 600 clinics across the United States. Joint Corp provides convenient, affordable, and accessible chiropractic services, focusing on subluxation correction and wellness care. Over the years, the company has developed a reputation for its patient-centered approach, fostering long-term relationships with clients. With a strong commitment to promoting the benefits of chiropractic care, Joint Corp continues to expand its presence and deliver high-quality healthcare services to individuals seeking natural pain relief and improved mobility.

Joint Corp, a leading company in the chiropractic care industry, has achieved several significant milestones in its journey. Over the years, Joint Corp has successfully expanded its network of chiropractic clinics across the United States, providing accessible and high-quality care to thousands of patients. The company also went public in 2014, increasing its financial stability and allowing for further growth and innovation. Joint Corp has been recognized for its exceptional franchise model, attracting talented chiropractors to join its team and contribute to its success. Through strategic partnerships and continuous advancements in technology, Joint Corp continues to solidify its position as a trusted and pioneering name in the chiropractic care market.

The Joint Corp is a dynamic and innovative company that focuses on revolutionizing the chiropractic care industry. With a commitment to improving the quality of life for their patients, the Joint Corp values convenience, affordability, and accessibility. Their corporate philosophy revolves around providing exceptional chiropractic services that are easily accessible to individuals from all walks of life. By offering affordable pricing and eliminating the need for insurance, the Joint Corp aims to make chiropractic care a staple in everyone's wellness routine. Their dedication to patient satisfaction, superior service, and positive outcomes sets them apart in the healthcare industry.

Analysts currently set an average price target of 20.00 USD for the Joint stock (median: 20.00 USD), implying +177.6 % versus the latest price. The consensus is based on 10 analyst ratings.

10 analysts currently rate the Joint stock: 6 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Joint to generate revenue of 60.90 M USD and earnings per share of 0.25 USD.

Converted at the current exchange rate, the Joint share trades at 6.43 EUR (7.20 USD).

The Joint share (JYNT) is listed on 1 stock exchanges, including: NASDAQ (JYNT).

The company Joint Corp is a company specializing in the healthcare industry. With over 520 locations in the USA, the company is a leading provider of chiropractic services. The business model of Joint Corp is based on providing chiropractic services. The company offers a wide range of services to help people relieve their pain and discomfort. The services mainly focus on improving the mobility and function of the neck, back, shoulders, and other areas of the body. Joint Corp also offers various products to help alleviate painful symptoms. These include things like special pillows and sleep masks that help people sleep better. In addition, Joint Corp also offers dietary supplements that are intended to improve overall body health. The company also uses various marketing strategies to attract customers. These include digital marketing campaigns and marketing on social media. Joint Corp also collaborates with third-party partners and ensures that the staff in customer contact is friendly and courteous. The company seems to be successful as it is experiencing steady growth and successfully offers its services. Joint Corp has various divisions. The main business division is chiropractic services. In addition, the company is also involved in the healthcare products sector. Joint Corp also has a range of wellness and health programs. These programs are designed to help customers improve their mobility and function and promote their overall health. Joint Corp is a company dedicated to providing chiropractic services. It uses various marketing strategies to attract customers and offers a wide range of products to help people with pain and discomfort. In addition, Joint Corp offers various wellness and health programs. In summary, Joint Corp is a company dedicated to improving the health and well-being of its customers.

The expected revenue of Joint is 60.90 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Joint is 3.63 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Joint is currently 28.92. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Joint stock.

The price-to-sales ratio (P/S) of Joint is currently 1.73. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Joint stock.

The Eulerpool Quality Score for Joint is 2/10.

The ISIN of Joint is US47973J1025. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Joint is A12FCC. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Joint is JYNT. The ticker symbol is used to trade Joint shares on the stock exchange.

Fair ValueTerminal
5.98 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
271,760.35 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website thejoint.com
Currency
USD
Initial public offering
Nov 11, 2014
ISIN
US47973J1025
Cusip
47973J102
Sedol
BRK0127
Market capitalization
109.04 M USDMicro Cap
52-Week Range
PEG
4.68
P/E ratio
P/Ee 2026
30.02
P/Ee 2027
18.32
P/Ee 2028
24.02
P/S
P/Se
1.73
EV/EBIT
—
P/B Ratio
7.24
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
17.04 %
Last updated Oct 27, 2026, 12:32 AM

Joint Ticker

NASDAQ · JYNT

Joint FIGI

JYNT:US · BBG0074VSJJ9JYNT:UA · BBG0074VSJN4JYNT:UC · BBG0074VSJP2JYNT:UN · BBG0074VSJR0JYNT:UP · BBG0074VSJS9JYNT:UB · BBG0074VSJV5JYNT:UM · BBG0074VSJX3JYNT:UX · BBG0074VSJY2JYNT:UR · BBG0074VSJZ1JYNT:UD · BBG0074VSK42JYNT:UF · BBG0074VSK79JYNT:VY · BBG0074VSK88

All fundamentals and in-depth analysis of Joint

Our stock analysis for Joint stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Joint. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.